Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Admiral FY profits surge on strong UK motor performance, dividend hiked

(Sharecast News) - Admiral hiked its dividend on Thursday as the insurer posted a surge in full-year profit, attributing much of the strength to its UK motor business. In the year to the end of December, pre-tax profit jumped 90% to £839.2m, with group turnover 28% higher at £6.15bn and insurance revenue up 37% at £4.78bn.

Earnings per share rose to 216.6p from 111.2p and the company declared a dividend of 192p per share, up 86%.

Group customer numbers grew 14% to 11.10 million, while UK insurance customer numbers were up 19% to 8.80m. The number of international insurance customers dipped 3% to 2.10m.

The UK motor division saw a 15% jump in customer numbers, "driven by reducing prices ahead of the market around the start of the year, after a period of prices moving higher to address significant claims cost inflation in the past few years".

Turnover in the UK motor segment was up £1.1bn to £4.5bn and pre-tax profit rose 61% on the previous year to £955m. Admiral said this was thanks to its strong performance as well as a circa £100m reserving benefit from the recent change to the Ogden discount rate, which impacts large personal injury claims.

The insurer said it passed the benefits from the new Ogden rate to its customers by lowering prices accordingly the day after the announcement in December.

Chief executive Milena Mondini de Focatiis said 2024 had been "a remarkable year".

"To remain one of the most competitive insurers for the largest number of people is a priority for us. We have emerged from several rather challenging years so when we saw conditions improve we were quick to respond. We were one of the first to reduce prices in response to easing inflation and cut rates the day after the favourable Ogden rate change announcement," she said.

"The main driver of our exceptional performance was our UK Motor business. However, it is great to see UK Household, Admiral Money, and our French and US Motor businesses all report a double-digit profit.

"As we enter into 2025, the market is softening, and the outlook is uncertain. Our priority is to stay efficient and agile so that we can adapt as needed and deliver long-term growth by building on our strong foundations and talented team."

At 0950 GMT, the shares were up 6.3% at 3,084p.

Russ Mould, investment director at AJ Bell, said: "The market was in the mood to salute insurance outfit Admiral, whose shares moved to a three-year high as it unveiled a bumper set of results which included a big increase in the dividend.

"The company's motor division looks to be returning to the fast lane after a period of being held up by higher claims and costs. Admiral's ability to cut prices has attracted drivers in their droves and the changes in the Ogden rate - which dictates the level of compensation in personal injury cases - have helped support a big increase in profit.

"UK motor insurance was the main engine of growth but most other areas of the business contributed decent growth too, bar the Italian arm where the company has a job to improve performance.

"Finishing the integration of pet insurance specialist More Than also means Admiral has another string to its bow which should now be firing on all cylinders."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.